Financial Counselors Inc Teva Pharmaceutical Industries LTD Transaction History

Financial Counselors Inc

$6.67 Billion
Q3 2024

A detailed history of Financial Counselors Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Financial Counselors Inc holds 56,472 shares of TEVA stock, worth $966,800. This represents 0.02% of its overall portfolio holdings.

Number of Shares

56,472

Previous 56,581 0.19%

Holding current value

$966,800

Previous $919,000 10.66%

% of portfolio

0.02%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $1,723 - $2,066	-109 Reduced 0.19%	56,472 $1.02 Million
Q2 2024 Aug 01, 2024	SELL	$12.78 - $17.4 $6,415 - $8,734	-502 Reduced 0.88%	56,581 $919,000
Q1 2024 May 02, 2024	SELL	$10.67 - $14.43 $10,179 - $13,766	-954 Reduced 1.64%	57,083 $805,000
Q4 2023 Jan 26, 2024	SELL	$8.12 - $10.63 $12,447 - $16,295	-1,533 Reduced 2.57%	58,037 $605,000
Q3 2023 Nov 07, 2023	BUY	$7.48 - $10.7 $12,506 - $17,890	1,672 Added 2.89%	59,570 $607,000
Q2 2023 Jul 27, 2023	SELL	$7.2 - $9.47 $14,464 - $19,025	-2,009 Reduced 3.35%	57,898 $436,000
Q1 2023 May 02, 2023	SELL	$8.36 - $11.37 $2,273 - $3,092	-272 Reduced 0.45%	59,907 $530,000
Q4 2022 Feb 14, 2023	SELL	$7.95 - $9.48 $19,914 - $23,747	-2,505 Reduced 4.0%	60,179 $549,000
Q3 2022 Nov 01, 2022	SELL	$6.86 - $11.95 $1.95 Million - $3.4 Million	-284,313 Reduced 81.94%	62,684 $506,000
Q2 2022 Aug 02, 2022	SELL	$7.38 - $10.4 $55,807 - $78,644	-7,562 Reduced 2.13%	346,997 $2.61 Million
Q1 2022 Apr 28, 2022	BUY	$7.33 - $9.39 $318,246 - $407,685	43,417 Added 13.95%	354,559 $3.33 Million
Q4 2021 Feb 10, 2022	SELL	$7.9 - $10.19 $48,506 - $62,566	-6,140 Reduced 1.94%	311,142 $2.49 Million
Q3 2021 Oct 26, 2021	BUY	$8.38 - $10.18 $245,265 - $297,948	29,268 Added 10.16%	317,282 $3.09 Million
Q2 2021 Aug 03, 2021	BUY	$9.9 - $11.56 $90,218 - $105,346	9,113 Added 3.27%	288,014 $2.85 Million
Q1 2021 Apr 29, 2021	BUY	$10.34 - $12.81 $252,999 - $313,435	24,468 Added 9.62%	278,901 $3.22 Million
Q4 2020 Feb 10, 2021	BUY	$8.61 - $11.04 $107,211 - $137,470	12,452 Added 5.15%	254,433 $2.46 Million
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $75,475 - $111,760	8,807 Added 3.78%	241,981 $2.18 Million
Q2 2020 Aug 07, 2020	BUY	$8.12 - $13.12 $24,806 - $40,081	3,055 Added 1.33%	233,174 $2.88 Million
Q1 2020 Apr 23, 2020	BUY	$6.69 - $13.45 $396,971 - $798,096	59,338 Added 34.75%	230,119 $2.07 Million
Q4 2019 Jan 31, 2020	SELL	$6.53 - $10.72 $269,258 - $442,028	-41,234 Reduced 19.45%	170,781 $1.67 Million
Q3 2019 Nov 08, 2019	BUY	$6.16 - $9.6 $411,019 - $640,550	66,724 Added 45.92%	212,015 $1.46 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $39,430 - $76,336	4,856 Added 3.46%	145,291 $1.34 Million
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $243,515 - $312,756	15,630 Added 12.52%	140,435 $2.2 Million
Q4 2018 Feb 01, 2019	BUY	$14.59 - $23.84 $12,722 - $20,788	872 Added 0.7%	124,805 $1.92 Million
Q3 2018 Oct 30, 2018	SELL	$21.06 - $25.65 $13,710 - $16,698	-651 Reduced 0.52%	123,933 $2.67 Million
Q2 2018 Aug 03, 2018	SELL	$16.77 - $24.71 $18,547 - $27,329	-1,106 Reduced 0.88%	124,584 $3.03 Million
Q1 2018 Apr 26, 2018	BUY	$16.68 - $22.07 $469,408 - $621,093	28,142 Added 28.85%	125,690 $2.15 Million
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $938,625 - $1.6 Million	-83,582 Reduced 46.14%	97,548 $1.85 Million
Q3 2017 Nov 13, 2017	BUY	$15.41 - $32.17 $624,582 - $1.3 Million	40,531 Added 28.83%	181,130 $3.19 Million
Q2 2017 Aug 10, 2017	BUY	N/A	140,599	140,599 $4.67 Million

Others Institutions Holding TEVA

# of Institutions

624

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account

Financial Counselors Inc Teva Pharmaceutical Industries LTD Transaction History